● Covered by 1 source · 1 reportMedium impact
Reed Jobs' Yosemite firm focuses on cancer solutions and biotech innovation
Key points
- Yosemite focuses solely on oncology, representing 40% of biotech industry.
- Jobs emphasizes creating new companies from early academic research.
- AI is increasingly integrated into Yosemite's operations and strategies.
Overview of Reed Jobs and Yosemite
Reed Jobs, son of Steve Jobs, is focusing on his work with Yosemite, a venture firm he founded in 2023. Rather than discussing his legacy, Jobs emphasizes his passion for oncology and advancing cancer treatments through innovative approaches.
Yosemite's Unique Approach
Yosemite differentiates itself by exclusively working in oncology, aiming to construct companies from scratch using early-stage academic research. Jobs believes the future of cancer treatment is not within existing pharmaceutical companies but rather in new innovations arising from universities.
Integration of AI in Operations
With the rapid advancement of artificial intelligence, Yosemite has begun integrating AI into its drug discovery process and clinical trial design. This shift reflects the growing significance of AI in the biotech industry and the opportunities it presents for developing new therapies.
Current State of Yosemite
Yosemite has grown to a team of 17 and is actively engaged in various projects, including notable startups like Azalea and Quarry. The firm is targeting a second fund of $350 million, demonstrating substantial traction and interest in its mission.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Reed Jobs launched the oncology-focused venture firm Yosemite in 2023, aiming to create biotech companies from academic research. The firm is expanding its focus, integrating AI into drug discovery and clinical trial design amidst a wave of new opportunities following patent expirations for existing drugs.